PAK3: p21 (RAC1) Activated Kinase 3

A key regulator of neuronal development, synaptic plasticity, and intellectual disability

Gene Information Card

Symbol PAK3
Full Name p21 (RAC1) Activated Kinase 3
Gene Type protein-coding
Chromosomal Location Xq23
NCBI Gene ID 5063 ncbi.nlm.nih.gov/gene/5063
Ensembl ID ENSG00000170264
UniProt ID O75914
OMIM ID 300142
HGNC ID 8592
Aliases PAK3beta, PAK3gamma, bPAK, hPAK3, MRX30, MRX47, OPHN3

Description

PAK3 (p21 (RAC1) Activated Kinase 3) encodes a member of the PAK family of serine/threonine protein kinases. These kinases are effectors of the small GTPases CDC42 and RAC1 and play critical roles in cytoskeletal dynamics, cell motility, and signal transduction. PAK3 is highly expressed in the brain and is essential for neuronal development, dendritic spine morphogenesis, and synaptic plasticity. Mutations in PAK3 cause X-linked intellectual disability (XLID) and have been associated with autism spectrum disorder.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
X-linked intellectual disability (XLID) Loss-of-function mutations impair PAK3 kinase activity, disrupting downstream signaling pathways (e.g., LIMK1/cofilin) required for actin cytoskeleton remodeling and dendritic spine formation. ClinVar, OMIM #300142
Autism spectrum disorder (ASD) Rare missense variants in PAK3 may alter synaptic protein interactions and neuronal connectivity. ClinVar, literature (e.g., PMID: 23453855)
Non-syndromic intellectual disability Deletions or truncating mutations in PAK3 lead to reduced protein expression and impaired cognitive function. OMIM #300142, HGNC

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 25.6 High
Testis 8.3 Medium
Lung 4.1 Low
Heart 3.5 Low
Liver 1.2 Not detected
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 18.4 High expression; used for neuronal differentiation studies
HeLa (cervical carcinoma) 6.7 Moderate expression
HEK293 (embryonic kidney) 5.2 Moderate expression
HepG2 (hepatocellular carcinoma) 2.1 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.419G>A (p.Arg140Gln) Missense Rare Reduced kinase activity; associated with XLID
c.1045C>T (p.Arg349*) Nonsense Rare Premature truncation; loss of function
c.124_125del (p.Leu42Valfs*5) Frameshift Rare Loss of protein function
c.1013A>G (p.Tyr338Cys) Missense Rare Impaired interaction with CDC42/RAC1
Mutation functional classification

Loss of Function (LOF)

Most PAK3 mutations associated with intellectual disability are loss-of-function, including nonsense, frameshift, and missense variants that reduce kinase activity or protein stability.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported in PAK3.

Dominant Negative (DN)

Some missense mutations (e.g., p.Arg140Gln) may act in a dominant-negative manner by interfering with wild-type PAK3 signaling in heterozygotes (X-linked inheritance).

Pathways

• RAC1/CDC42-PAK signaling pathway
• Regulation of actin cytoskeleton (KEGG: hsa04810)
• Axon guidance (KEGG: hsa04360)
• Neurotrophin signaling pathway (KEGG: hsa04722)
• Focal adhesion (KEGG: hsa04510)

Protein Summary

PAK3 is a 559-amino acid serine/threonine kinase with an N-terminal p21-binding domain (PBD) that binds activated CDC42 and RAC1, and a C-terminal kinase domain. Autoinhibition is relieved upon GTPase binding, leading to kinase activation. PAK3 phosphorylates substrates including LIMK1, which inactivates cofilin to stabilize actin filaments. In neurons, PAK3 regulates dendritic spine morphology, synaptic plasticity, and learning. Loss of PAK3 function underlies X-linked intellectual disability.

Related Products

Product name Cat.No. Species Gene ID
PAK3 Knockout HEK293 Cell Line EDJ-KQ1239 Human 5063 Details Get a Quote
PAK3 Knockout HeLa Cell Line EDJ-KQ54076 Human 5063 Details Get a Quote
PAK3 Knockout A-549 Cell Line EDJ-KQ62564 Human 5063 Details Get a Quote
PAK3 Knockout HCT 116 Cell Line EDJ-KQ71034 Human 5063 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: